The relationship between regional abdominal fat distribution and both insulin resistance and subclinical chronic inflammation in non-diabetic adults

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Hsieh, Ching Jung ^a   Wang, Pei Wen ^a   Chen, Tse Ying ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Adiponectin; High sensitive C reactive protein; Insulin resistance; Intra peritoneal fat; Retroperitoneal fat; Subcutaneous fat

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL FAT; ADIPOSE TISSUE; ADULT; AGE; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; CHRONIC INFLAMMATION; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INTRAPERITONEAL FAT; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROPERITONEAL FAT; SEX; SUBCUTANEOUS FAT; TAIWAN;

EID: 84898406011     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-49     Document Type: Article

References (38)

1. Obesity and its related diseases in Taiwan. Hung KC, Obes Rev 2005 6 271 274 10.1111/j.1467-789X.2005.00175.x 16246212 (Pubitemid 41581636)
2. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. Langenberg C, Sharp SJ, Schulze MB, Rolandsson O, Overvad K, Forouhi NG, Spranger J, Drogan D, Huerta JM, Arriola L, de Lauzon-Guillan B, Tormo MJ, Ardanaz E, Balkau B, Beulens JW, Boeing H, Bueno-de-Mesquita HB, Clavel-Chapelon F, Crowe FL, Franks PW, Gonzalez CA, Grioni S, Halkjaer J, Hallmans G, Kaaks R, Kerrison ND, Key TJ, Khaw KT, Mattiello A, InterAct Consortium, et al. PLoS Med 2012 9 1001230 10.1371/journal.pmed.1001230 22679397
3. Abdominal adiposity and cardiometabolic risk: do we have all the answer? Haffner SM, Am J Med 2007 120 9 Suppl 1 10 S16
4. Adipose tissue dysfunction in nascent metabolic syndrome. Bremer AA, Jialal I, J Obese 2013 2013 393192
5. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, Keaney JF Jr, Meigs JB, Lipinska I, Kathiresan S, Murabito JM, O'Donnell CJ, Benjamin EJ, Fox CS, Circulation 2007 116 1234 1241 10.1161/CIRCULATIONAHA.107. 710509 17709633 (Pubitemid 47517534)
6. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Tilg H, Moschen AR, Nat Rev Immunol 2006 6 772 783 10.1038/nri1937 16998510 (Pubitemid 44453463)
7. Adipokines and insulin resistance. Rabe K, Lehrke M, Parhofer KG, Broedl UC, Mol Med 2008 14 741 1751 19009016
8. Visceral fat mass is always, but adipokines (adiponectin and resistin) are diversely associated with insulin resistance in Chinese type 2 diabetic and normoglycemic subjects. Bu J, Feng Q, Ran J, Li Q, Mei G, Zhang Y, Diabetes Res Clin Pract 2012 96 163 169 10.1016/j.diabres.2011.12.014 22244787
9. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. McLaughlin T, Lamendola C, Liu A, Abbasi F, J Clin Endocrinol Metab 2011 96 1756 E1760 10.1210/jc.2011-0615 21865361
10. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Preis SR, Massaro JM, Robins SJ, Hoffmann U, Vasan RS, Irlbeck T, Meigs JB, Sutherland P, D'Agostino RB Sr, O'Donnell CJ, Fox CS, Obesity 2010 18 2191 21988 10.1038/oby.2010.59 20339361
11. Visceral fat is a strong predictor of insulin resistance regardless of cardiorespiratory fitness in non-diabetic people. Usui C, Asaka M, Kawano H, Aoyama T, Ishijima T, Sakamoto S, Higuchi M, J Nutr Sci Vitaminol 2010 56 109 116 10.3177/jnsv.56.109 20495292
12. A multicompartment body composition technique based on computerized tomography. Chowdhury B, Sjostrom L, Alpsten M, Kostanty J, Kvist H, Lofgren R, Int J Obes Relat Metab Disord 1994 18 219 234 8044196 (Pubitemid 24123457)
13. Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. Abate N, Burns D, Peshock RM, Garg A, Grundy S, J Lipid Res 1994 35 1490 1496 7989873 (Pubitemid 24251044)
14. The morphology and metabolism of intraabdominal adipose tissue in men. Mårin P, Andersson B, Ottosson M, Olbe L, Chowdhury B, Kvist H, Holm G, Sjöström L, Björntorp P, Metabolism 1992 41 1242 1248 10.1016/0026-0495(92)90016-4 1435298
15. Relationships of generalized and regional adiposity to insulin sensitivity in men. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM, J Clin Invest 1995 96 88 98 10.1172/JCI118083 7615840
16. Lean, nondiabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. Liew CF, Seah ES, Yeo KP, Lee KO, Wise SD, Int J Obes Relat Metab Disord 2003 27 784 789 10.1038/sj.ijo.0802307 12821962 (Pubitemid 36819534)
17. Ethnic differences in body composition and the associated metabolic profile: a comparative study between Asians and Caucasians. Wulan SN, Westerterp KR, Plasqui G, Maturitas 2010 65 315 319 10.1016/j.maturitas.2009.12.012 20079586
18. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. Raji A, Seely EW, Arky RA, Simonson DC, J Clin Endocrinol Metab 2001 86 5366 5371 10.1210/jcem.86.11.7992 11701707 (Pubitemid 33070261)
19. Low body mass index but high percent body fat in Taiwanese subjects: implications of obesity cutoffs. Chang CJ, Wu CH, Chang CS, Yao WJ, Yang YC, Wu JS, Lu FH, Int J Obes Relat Metab Disord 2003 27 253 259 10.1038/sj.ijo.802197 12587007 (Pubitemid 36255809)
20. The relation of body fat mass and distribution to markers of chronic inflammation. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM, Int J Obes Relat Metab Disord 2001 25 1407 1415 10.1038/sj.ijo.0801792 11673759 (Pubitemid 32977855)
21. The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C, Atherosclerosis 2005 183 308 315 10.1016/j.atherosclerosis.2005.03.010 16285994 (Pubitemid 41579282)
22. Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women. Smith J, Al-Amri M, Sniderman A, Cianflone K, Nutr Metab 2006 3 18 10.1186/1743-7075-3-18
23. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F, Centers for Disease Control and Prevention; American Heart Association, Circulation 2003 107 499 511 10.1161/01.CIR.0000052939.59093. 45 12551878 (Pubitemid 36158056)
24. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Forouhi NG, Sattar N, McKeigue PM, Int J Obes Relat Metab Disord 2001 25 1327 1331 10.1038/sj.ijo.0801723 11571595 (Pubitemid 32835450)
25. Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy nonobese people. Lapice E, Maione S, Patti L, Cipriano P, Rivellese AA, Riccardi G, Vaccaro O, Diabetes Care 2009 32 1734 1736 10.2337/dc09-0176 19587368
26. Role of adipokines in cardiovascular disease. Mattu HS, Randeva HS, J Endocrinol 2013 216 17 T36 10.1530/JOE-12-0232 23160967
27. The role of TNF-alpha in insulin resistance. Borst SE, Endocrine 2004 23 177 182 10.1385/ENDO:23:2-3:177 15146098 (Pubitemid 39140231)
28. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD, Bryer-Ash M, Norris JM, Haffner SM, J Clin Endocrinol Metab 2007 92 2665 2671 10.1210/jc.2006-2614 17426091 (Pubitemid 47037374)
29. Effectiveness of weight loss in the elderly with type 2 diabetes mellitus. Hsieh CJ, Wang PW, J Endocrinol Invest 2005 28 973 977 16483174 (Pubitemid 43265761)
30. Plasma leptin in non-diabetic Asian Indians: association with abdominal adiposity. Ramachandran A, Snehalatha C, Vijay V, Satyavani K, Latha E, Haffner SM, Diabet Med 1997 14 937 941 10.1002/(SICI)1096-9136(199711)14:11<937::AID- DIA502>3.0.CO;2-S 9400917 (Pubitemid 27492184)
31. Adipokines and body fat composition in South Asians: results of the Metabolic Syndrome and Atherosclerosis in South Asians Living in America (MASALA) study. Shah A, Hernandez A, Mathur D, Budoff MJ, Kanaya AM, Int J Obes 2012 36 810 816 10.1038/ijo.2011.167
32. Circulating levels of high molecular weight (HMW) adiponectin and total adiponectin in relation to fat distribution, oxidative stress and inflammation in Asian Indians. Indulekha K, Surendar J, Anjana RM, Gokulakrishnan K, Balasubramanyam M, Aravindhan V, Mohan V, Dis Markers 2012 33 185 192 10.1155/2012/672939 22960344
33. Relationships between circulating adiponectin levels and fat distribution in obese subjects. Kishida K, Kim KK, Funahashi T, Matsuzawa Y, Kang HC, Shimomura I, J Atheroscler Thromb 2011 18 592 595 10.5551/jat.7625 21378472
34. The role of resistin in obesity-induced insulin resistance. Haluzik M, Haluzikova D, Curr Opin Investig Drugs 2006 7 306 311 16625816
35. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Piche ME, Lemieux S, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J, Am J Cardiol 2005 96 92 97 10.1016/j.amjcard.2005.02.051 15979442 (Pubitemid 40853948)
36. Health ABC study: Inflammation and race and gender differences in computerized tomography-measured adipose depots. Beasley LE1, Koster A, Newman AB, Javaid MK, Ferrucci L, Kritchevsky SB, Kuller LH, Pahor M, Schaap LA, Visser M, Rubin SM, Goodpaster BH, Harris TB, Obesity 2009 17 1062 1069 10.1038/oby.2008.627 19165157
37. Role of resistin in inflammation and inflammation-related diseases. Pang SS, Le YY, Cell Mol Immunol 2006 3 29 34 16549046
38. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN, Am J Physiol Endocrinol Metab 2005 288 454 E461 10.1152/ajpendo.00203.2004 15522994 (Pubitemid 40110656)